Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge Eating Disorder

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

Canada ,Michigan ,United States ,Canadian ,Abby Berger ,Greg Mckee ,Joseph Green ,Strategic Communications ,University Of Florida ,Drug Administration ,Edison Group ,University Of Michigan ,Investigational New Drug ,Psilocybin For Neuropsychiatric Disorders ,Technology ,Business ,Health ,Pr Newswire ,Clinical Trials ,Eating Disorders ,